Jiangsu, China

Yan Ni

This inventor holds 1 USPTO granted patent. Top assignee: Biomics Biotechnologies, Co., Ltd.. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yan Ni. Retrieved from https://idiyas.com/inventor/yan-ni-n1129l0c

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yan Ni - Innovator in Liposome Formulation

Introduction

Yan Ni is a prominent inventor based in Jiangsu, China. She has made significant contributions to the field of biotechnology, particularly in the development of liposome formulations for therapeutic applications. Her innovative work focuses on addressing diseases caused by abnormal gene expression.

Latest Patents

Yan Ni holds a patent for a liposome preparation, its preparation method, and its application in treating diseases linked to abnormal gene expression. The patent describes a liposome formulation that includes complementary cationic lipid pairs, phospholipids, and long-circulating lipids. The preparation method involves mixing these components to create pre-formed vesicles, which are then combined with a nucleic acid solution to produce the liposome-nucleic acid formulation. This formulation is notable for its ease of preparation and effectiveness in delivering therapeutic agents in vivo.

Career Highlights

Yan Ni is associated with Biomics Biotechnologies, Co., Ltd., where she continues to advance her research and development efforts. Her work has the potential to significantly impact the treatment of various genetic disorders.

Collaborations

Yan Ni collaborates with notable colleagues, including Jianxin Chen and Wei Peng. These partnerships enhance her research capabilities and contribute to the innovative environment at Biomics Biotechnologies.

Conclusion

Yan Ni's contributions to liposome formulation represent a significant advancement in biotechnology. Her innovative approach to addressing genetic diseases showcases the potential of her work in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…